Header Logo

Connection

OLIVE ECKSTEIN to Mitogen-Activated Protein Kinase Kinases

Back to Details
This is a "connection" page, showing publications OLIVE ECKSTEIN has written about Mitogen-Activated Protein Kinase Kinases.
OLIVE ECKSTEIN
Connection Strength
0.172
Mitogen-Activated Protein Kinase Kinases
  1. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. J Clin Oncol. 2022 07 10; 40(20):2235-2245.
    View in: PubMed
    Score: 0.172
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.